BCS waiver [Dissolution / BCS / IVIVC]

posted by Mauricio Sampaio  – Brazil, 2016-05-18 17:58 (3679 d 11:29 ago) – Posting: # 16326
Views: 6,658

Hi!
Bad news for you!
According Capecitabine Product-Specific Bioequivalence Guidance from EMA, Capecitabine is an unstable compound in acidic medium. Absorption is almost complete. The available data on solubility does not allow its BCS classification. Then, I think that a possibility for biowaiver of capecitabine is impossible according current rules.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
167 visitors (0 registered, 167 guests [including 34 identified bots]).
Forum time: 05:28 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5